Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senate Finance Hearing To Focus Stark Self-Referral Law Exceptions

This article was originally published in The Gray Sheet

Executive Summary

The Senate Finance Committee plans to debate potential reforms and exceptions to the Stark self-referral law for health-care companies and physicians on July 12 to make the statute better support alternative Medicare payment models. And the committee has released a white paper on the topic.

You may also be interested in...



Take Compensation Pieces Out Of Stark Law, Legal Experts Tell Senators

Legal experts and a hospital CEO agreed at a Senate Finance Committee hearing that getting rid of the compensation components of the Stark Law barring physician self-referrals – while keeping in the ownership restrictions – may be the best way to protect patients from overuse of medical services while promoting value-based payment systems.

White House To Deliver 25 Million Face Masks To Low-Income Americans

The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.

HHS Secretary Nominee Becerra Commits To Telehealth Expansion, Procedure Price Transparency

At two recent confirmation hearings, HHS secretary nominee Xavier Becerra promised Senators he would help expand telehealth and procedure price transparency.

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT038419

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel